These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 29122155)

  • 41. Endophenotyping Oxaliplatin Hypersensitivity: Personalizing Desensitization to the Atypical Platin.
    Silver J; Garcia-Neuer M; Lynch DM; Pasaoglu G; Sloane DE; Castells M
    J Allergy Clin Immunol Pract; 2020 May; 8(5):1668-1680.e2. PubMed ID: 32112926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor.
    Della-Torre E; Conti A; Berti A; Yacoub MR; Alessio M
    Int J Rheum Dis; 2017 Feb; 20(2):276-279. PubMed ID: 28036157
    [No Abstract]   [Full Text] [Related]  

  • 43. Omalizumab and other biologics in drug desensitization.
    Fernandez J; Ruano-Zaragoza M; Blanca-Lopez N
    Curr Opin Allergy Clin Immunol; 2020 Aug; 20(4):333-337. PubMed ID: 32398420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group.
    Scherer K; Brockow K; Aberer W; Gooi JH; Demoly P; Romano A; Schnyder B; Whitaker P; Cernadas JS; Bircher AJ;
    Allergy; 2013 Jul; 68(7):844-52. PubMed ID: 23745779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions.
    Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ
    Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions.
    Picard M; Pur L; Caiado J; Giavina-Bianchi P; Galvão VR; Berlin ST; Campos SM; Matulonis UA; Castells MC
    J Allergy Clin Immunol; 2016 Apr; 137(4):1154-1164.e12. PubMed ID: 26725998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methotrexate hypersensitivity reactions in pediatrics: Evaluation and management.
    Dilley MA; Lee JP; Broyles AD
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27786403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Desensibilización a Rituximab en paciente con proteinuria persistente secundaria a LES].
    Servín-Suárez N; Méndez-Gómez A; Korkowski-Uviña K; Carrillo-Murillo H; Torres-Rojo E; Ortega-Cisneros M; Ochoa-García IV
    Rev Alerg Mex; 2023 Sep; 70(4):. PubMed ID: 37933938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease.
    Chen JR; Buchmiller BL; Khan DA
    J Allergy Clin Immunol Pract; 2015; 3(6):926-31.e1. PubMed ID: 26282158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune-Related Adverse Drug Reactions and Immunologically Mediated Drug Hypersensitivity.
    Macy E
    Immunol Allergy Clin North Am; 2020 Nov; 40(4):635-647. PubMed ID: 33012325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity.
    Legere HJ; Palis RI; Rodriguez Bouza T; Uluer AZ; Castells MC
    J Cyst Fibros; 2009 Dec; 8(6):418-24. PubMed ID: 19740711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies.
    Sloane D; Govindarajulu U; Harrow-Mortelliti J; Barry W; Hsu FI; Hong D; Laidlaw T; Palis R; Legere H; Bunyavanich S; Breslow R; Wesemann D; Barrett N; Brennan P; Chong HJ; Liu A; Fernandez J; Fanning L; Kyin T; Cahill K; Bankova L; Lynch A; Berlin S; Campos S; Fuchs C; Mayer R; Matulonis U; Castells M
    J Allergy Clin Immunol Pract; 2016; 4(3):497-504. PubMed ID: 26895621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol.
    Syrigou E; Dannos I; Kotteas E; Makrilia N; Tourkantonis I; Dilana K; Gkiozos I; Saif MW; Syrigos KN
    Int Arch Allergy Immunol; 2011; 156(3):320-4. PubMed ID: 21720178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IgE-mediated allergy and desensitization to factor IX in hemophilia B.
    Dioun AF; Ewenstein BM; Geha RS; Schneider LC
    J Allergy Clin Immunol; 1998 Jul; 102(1):113-7. PubMed ID: 9679854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions.
    Patil SU; Long AA; Ling M; Wilson MT; Hesterberg P; Wong JT; Banerji A
    J Allergy Clin Immunol; 2012 Feb; 129(2):443-7. PubMed ID: 22099941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children.
    Hong DI; Dioun AF
    J Allergy Clin Immunol Pract; 2014; 2(1):13-9; quiz 20. PubMed ID: 24565764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Desensitization for the prevention of drug hypersensitivity reactions.
    Kang SY; Seo J; Kang HR
    Korean J Intern Med; 2022 Feb; 37(2):261-270. PubMed ID: 35123386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Linezolid desensitization for a patient with multiple medication hypersensitivity reactions.
    Bagwell AD; Stollings JL; White KD; Fadugba OO; Choi JJ
    Ann Pharmacother; 2013; 47(7-8):e30. PubMed ID: 23715068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Management and choice of antibiotics for patients with an allergy to penicillin].
    Rijnders BJ; Ceuppens JL; Peetermans WE
    Ned Tijdschr Geneeskd; 1999 Feb; 143(7):336-41. PubMed ID: 10221094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypersensitivity to Rituximab in Children.
    Liccioli G; Simonini G; Melani F; Giovannini M; Ricci S; Sarti L; Cavallin M; Barni S; Marrani E; Mori F
    Pharmacology; 2021; 106(5-6):341-344. PubMed ID: 33202411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.